Peter Ginter, Fotograf / Bayer AG
This photograph was awarded 2. place in the category "Faces of Research".About 1,200 employees at Bayer’s U.S. location in Berkeley symbolically present the result of their annual production: 200 grams of genetically manufactured blood clotting factor VIII. The medication is produced in a very elaborate process to save the lives of hemophiliacs. The disorder is caused by missing or defective blood clotting proteins. Das Bild darf ausschließlich im Zusammenhang mit der Berichterstattung über den Wettbewerb "Bilder der Forschung" rechtefrei heruntergeladen und verwendet werden. Das Copyright liegt bei dem jeweiligen Fotografen.